Brief: WuXi AppTec To Own 2.6% Stake In Lyell Immunopharma
18/06/2021 11:22
June 18 (Reuters) - WuXi AppTec Co Ltd 603259.SS :
* SAYS IT WILL OWN 2.6% STAKE IN LYELL IMMUNOPHARMA INC
AFTER
COMPLETION OF LYELL'S GLOBAL OFFERING
Source text in Chinese: https://bit.ly/3wCI6Yj
Further company coverage: 603259.SS 2359.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma